A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback